Thu, March 21, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Scott Stember Maintained (WGO) at Hold and Held Target at $70 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Seth Basham Reiterated (WSM) at Buy with Decreased Target to $165 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Jason Haas Maintained (WSM) at Hold with Increased Target to $149 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Barton Crockett Upgraded (WBD) to Hold and Increased Target to $10 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Gary Tenner Maintained (WAL) at Strong Buy and Held Target at $85 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Heiko Ihle Reiterated (VZLA) at Strong Buy and Held Target at $3.25 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Joseph Pantginis Reiterated (BNOX) at Strong Buy and Held Target at $8 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Etzer Darout Maintained (BNTX) at Buy with Decreased Target to $123 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Bill Maughan Reiterated (BNTX) at Strong Buy and Held Target at $171 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Mark Palmer Initiated (btdr) at Strong Buy and Held Target at $13 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Jonathan Komp Maintained (BOOT) at Hold with Increased Target to $90 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Yi Chen Maintained (brns) at Strong Buy with Decreased Target to $8 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Taylor McGinnis Upgraded (BRZE) to Strong Buy and Held Target at $62 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Parash Jain Maintained (ZTO) at Strong Buy with Decreased Target to $30 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Lin Chen Maintained (ZTO) at Buy with Decreased Target to $30 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Fan Tso Upgraded (ZTO) to Strong Buy and Increased Target to $29 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Jason Ader Initiated (ZI) at Buy and Held Target at $20 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Kalpit Patel Maintained (VRDN) at Strong Buy with Decreased Target to $25 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Swayampakula Ramakanth Reiterated (VOR) at Strong Buy and Held Target at $18 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
David Nierengarten Reiterated (VOR) at Buy and Held Target at $11 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Stephen Willey Maintained (VOR) at Strong Buy with Decreased Target to $12 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Matthew Biegler Reiterated (VOR) at Buy with Decreased Target to $15 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Matthew Hedberg Reiterated (ALTR) at Hold and Held Target at $90 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Joseph Vafi Maintained (ALIT) at Strong Buy with Increased Target to $13 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Kevin Mcveigh Maintained (ALIT) at Strong Buy with Increased Target to $13 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Daniel Ives Maintained (ALIT) at Buy with Increased Target to $14 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Kyle Peterson Maintained (ALIT) at Strong Buy with Increased Target to $13 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Matt Howlett Reiterated (AJX) at Strong Buy with Decreased Target to $6 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Ronald Epstein Maintained (BA) at Hold with Decreased Target to $210 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Gavin Parsons Maintained (BA) at Strong Buy with Decreased Target to $250 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Charles Minervino Maintained (BA) at Buy with Decreased Target to $230 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Jason Ader Initiated (ADBE) at Sell and Held Target at $445 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Yi Chen Reiterated (ANIX) at Strong Buy and Held Target at $12 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Raghuram Selvaraju Reiterated (ANVS) at Strong Buy and Held Target at $30 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Jason Ader Initiated (AMPL) at Hold on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Wilma Burdis Initiated (AMP) at Hold on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
David Amsellem Maintained (AMRX) at Buy with Increased Target to $8 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Swayampakula Ramakanth Reiterated (AVGR) at Strong Buy and Held Target at $5 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Cody Acree Reiterated (AVGO) at Strong Buy and Held Target at $172 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Harlan Sur Reiterated (AVGO) at Buy and Held Target at $170 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Hans Mosesmann Reiterated (AVGO) at Strong Buy and Held Target at $150 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Matthew Ramsay Upgraded (AVGO) to Buy and Increased Target to $150 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Anthony Crowdell Reiterated (AWK) at Strong Buy with Decreased Target to $131 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Joseph Feldman Reiterated (ASO) at Buy and Held Target at $83 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Michael Roxland Maintained (BCC) at Strong Buy with Increased Target to $175 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Laura Martin Reiterated (TTD) at Strong Buy and Held Target at $100 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Rodolfo Angele Maintained (TX) at Buy with Increased Target to $52 on, Mar 21st, 2024
[ Thu, Mar 21st 2024 ]: WOPRAI
Robert Driscoll Reiterated (TYRA) at Buy and Held Target at $28 on, Mar 21st, 2024

David Amsellem Maintained (AMRX) at Buy with Increased Target to $8 on, Mar 21st, 2024

David Amsellem of Piper Sandler, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Buy with Increased Target from $6 to $8 on, Mar 21st, 2024.

David has made no other calls on AMRX in the last 4 months.



There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David

  • Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $6.25 on, Monday, March 4th, 2024
  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $8 on, Monday, January 29th, 2024